2m 2m 2m 2m 2m 2m 2m
Arbutus Biopharm (ABUS)
NASDAQ
$4.20+$0.02 (+0.48%)
Price as of Oct 22, 2026 7:42 PM EDT- $640.7MMarket Cap
- -5.64%1-Year Change
- BiotechnologyIndustry
Arbutus Biopharm (ABUS)
$4.20+$0.02 (+0.48%)
ABUS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.18 | ||
Change | -$0.15 (-3.46%) | ||
Open | $4.32 | ||
High | $4.35 | ||
Low | $4.17 | ||
Previous Close | $4.33 | ||
Volume | 3,026,405 | ||
30-Day Average Volume | 7,399,343 | ||
1-Week Change | -0.24% | ||
1-Month Change | -16.40% | ||
1-Year Change | -5.64% | ||
3-Year Change | 140.23% | ||
5-Year Change | 1.70% | ||
Fundamentals | |||
Shares Outstanding | 153.3M | ||
Total Assets | $274.0M | ||
Market Cap | $640.7M | ||
Enterprise Value | $621.5M | ||
Period: QTR TTM FY | |||
Revenue | $202,000.00 | ||
Net Income | -$5.1M | ||
Free Cash Flow | -$6.0M | ||
EBIT | -$5.1M | ||
EBITDA | -$5.1M | ||
Net Working Capital | $270.5M | ||
EPS | -$0.03 | ||
Enterprise Value/EBITDA | -121 | ||
Enterprise Value/Revenue | 3,077 | ||
P/B | 2 | ||
P/E | -139 | ||
PEG | 1 | ||
Price/Free Cash Flow | -106 | ||
Price/Operating Cash Flow | -106 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue